This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Surgical treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Surgery usually is reserved for patients with severe Ménière's disease refractory to medical treatment (1):

Procedures which conserve hearing in Meniere's disease:

  • endolymphatic sac decompression:
    • the endolymph sac lies on the posterior surface of the petrous bone
    • decompression is performed by mastoidectomy and drained
  • division of vestibular nerve - may be done in association with a neurosurgeon; the vestibular nerves are approached through a middle fossa craniotomy. There is significant morbidity associated with this procedure and a risk of postoperative epilepsy (2)
  • ultrasonic destruction of the vestibular end organs - the lateral semi-circular canal is exposed by mastoidectomy and ultrasound applied

Total labyrinthectomy destroys inner ear function thus causing deafness but usually, relieving vertigo. It should only be undertaken if there is unilateral Meniere's disease and hearing loss is severe.

Seemingly irrelevant procedures have been found to be effective, for example the insertion of grommets, although symptoms may return when the grommets are taken out.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.